David Bamberger is an Infectious Disease physician affiliated with Kansas City University. OpenAlex indexes 62 publications with 2,485 citations (h-index 24).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2301 Holmes St
Kansas City, MO 641082640
Telephone
816-404-1885Provider last certified this registry record 19 Nov 2020.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Melinta Therapeutics, LLCProgram year20251 payment
- Gilead Sciences, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
43.6%Statin11.9%Atorvastatin Calcium75%Rosuvastatin Calcium16%Pravastatin Sodium6%Simvastatin4%Part D<11 patientsCalcium channel blocker7%Amlodipine Besylate95%Diltiazem 24hr Er (Cd)5%Part D<11 patients+ 11 more classes in this area
Nervous system
14.9%Opioid Agonist5.6%Oxycodone-Acetaminophen49%Tramadol Hcl27%Oxycodone Hcl24%Part D<11 patientsGabapentinoids4.1%Gabapentin91%Pregabalin9%Part D<11 patients+ 5 more classes in this area
Metabolism & gastrointestinal
13.7%Proton pump inhibitor3.8%Pantoprazole Sodium59%Omeprazole21%Esomeprazole Magnesium20%Part D<11 patientsSGLT2 inhibitor2.6%Jardiance75%Farxiga25%Part D<11 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Diagnostic value of magnetic resonance imaging and the outcomes of medical therapy in histologically confirmed diabetes-related foot osteomyelitis
Journal of Bone and Joint Infection
2025 - Nurse-led HIV Preexposure Prophylaxis in the United States: Landscape, Opportunities and Challenges
Medical Research Archives
2022 - <i>Staphylococcus aureus</i> Bacteremia: Contemporary Management.
PubMed
2021 - Trends in Sexually Transmitted Infections.
PubMed
2021
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”